Nanoviricides (NNVC) Non Operating Income (2010 - 2026)
Nanoviricides (NNVC) reported Non Operating Income of $22,885 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 16.0% from $19,722 a year earlier but down 44.0% from the prior quarter.
Powered by 
Analysis
Nanoviricides (NNVC) Non Operating Income (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides posted Non Operating Income of $87,852, down 29.5% from FY2025.
- Non Operating Income has declined for three consecutive fiscal years.
- By fiscal year, Non Operating Income came in at $124,679 in FY2025 (-43.8%), $221,965 in FY2024 (-37.5%), $354,895 in FY2023 and $6,736 in FY2022.
- Five-year quarterly Non Operating Income spans a low of -$4,789 in fiscal Q3 2022 and a high of $107,937 in fiscal Q3 2023.
- Year over year, Non Operating Income gained in two of the last eight quarters, with an average decline of 32.9%.
- The high point for year-over-year Non Operating Income in five years was fiscal Q4 2022 (growth of 817.2%); the low point was fiscal Q1 2026 (a decline of 71.7%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $40,885 (Q3 2026), $12,455 (Q2 2026) and $11,627 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Nanoviricides | 30.18 Mn | 17.84 Mn | - | 22,885.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,885.00 |
| Mar 31, 2026 | 40,885.00 |
| Dec 31, 2025 | 12,455.00 |
| Sep 30, 2025 | 11,627.00 |
| Jun 30, 2025 | 19,722.00 |
| Mar 31, 2025 | 32,373.00 |
| Dec 31, 2024 | 31,560.00 |
| Sep 30, 2024 | 41,023.00 |
| Jun 30, 2024 | 35,374.00 |
| Mar 31, 2024 | 53,927.00 |
| Dec 31, 2023 | 69,819.00 |
| Sep 30, 2023 | 62,845.00 |
| Jun 30, 2023 | 106,380.00 |
| Mar 31, 2023 | 107,937.00 |
| Dec 31, 2022 | 88,860.00 |
| Sep 30, 2022 | 51,718.00 |
| Jun 30, 2022 | 12,786.00 |
| Mar 31, 2022 | -4,789.00 |
| Dec 31, 2021 | -558.00 |
| Sep 30, 2021 | -703.00 |
API Access
Nanoviricides Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();